San Diego, CA -- (SBWire) -- 10/26/2022 --The Shareholders Foundation announced that a deadline is coming up on October 25, 2022 in the lawsuit filed for certain investors of Humanigen, Inc. (NASDAQ: HGEN).
Investors who purchased shares of Humanigen, Inc. (NASDAQ: HGEN) have certain options and there are strict and short deadlines running. Deadline: October 25, 2022. NASDAQ: HGEN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Humanigen, Inc. (NASDAQ: HGEN) common shares between May 28, 2021 and July 12, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 28, 2021 and July 12, 2022, the Defendants made false and/or misleading statements and/or failed to disclose that lenzilumab was less effective in treating hospitalized COVID-19 patients than Defendants had represented, that as a result, the FDA was unlikely to approve the lenzilumab EUA and the ACTIV-5/BET-B study was unlikely to meet its primary endpoint, that accordingly, lenzilumab's clinical and commercial prospects were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Humanigen, Inc. (NASDAQ: HGEN) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ:HGEN Investor Alert: Deadline on October 25, 2022 in Lawsuit Against Humanigen, Inc.
A Deadline is coming up on October 25, 2022 in the lawsuit for certain investors in Humanigen, Inc. (NASDAQ:HGEN).